4//SEC Filing
DelMar Pharmaceuticals, Inc. 4
Accession 0001213900-17-003327
$HURACIK 0001498382operating
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:22 PM ET
Size
4.8 KB
Accession
0001213900-17-003327
Insider Transaction Report
Form 4
BACHA JEFFREY
CEO and President10% Owner
Transactions
- Other
Common Stock
2017-03-31$3.20/sh+176$563→ 39,145 total
Footnotes (1)
- [F1]The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.
Documents
Issuer
DelMar Pharmaceuticals, Inc.
CIK 0001498382
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001498382
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 4:22 PM ET
- Size
- 4.8 KB